Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Mesothelioma: HELP
Andrew R. Haas
Based on 12 articles published since 2007
||||
Expertise Level
The expertise of Andrew R. Haas ranks in the
  • Top 0.19%
  • ... of 16,324 published authors worldwide on Mesothelioma
  • ... from 2007 through 2018
  • ... based on contributions to 12 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Haas, Andrew R   ·   Haas, Andrew
Work Locations
Details
Most likely:    University of Pennsylvania   Contact    
2016
  • Division of Hematologic Oncology of the University of Pennsylvania, 3400 Ciciv Center Boulevard, Perelman Center of Advanced Medicine, PA, USA. · Department of Gynecologic Oncology of the University of Pennsylvania, 3400 Ciciv Center Boulevard, Perelman Center of Advanced Medicine, PA, USA. · Section of Interventional Pulmonology & Thoracic Oncology of The University of Pennsylvania, 3400 Ciciv Center Boulevard, Perelman Center of Advanced Medicine, PA, USA. · Hospital of the University of Pennsylvania, 3400 Civic Center Boulevard, Jordan Center, Philadelphia, PA 19104, USA. · Pubmed 26973126
  • Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland. · Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Biostatistics & Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Merck & Co., Inc., Kenilworth, New Jersey. · Wistar Institute, Philadelphia, Pennsylvania. · Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Pubmed 26968202
2014
  • Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA ; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Pubmed 24579088
2013
  • Section of Interventional Pulmonology and Thoracic Oncology, Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, 833 West Gates Building, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA. · Pubmed 23411061
2012
  • Section of Interventional Pulmonology and Thoracic Oncology, Pulmonary, Allergy, and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, PA 19104-4283, USA. · Pubmed 22456231
2013
  • Authors' Affiliations: Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Pubmed 24777247
2011
  • Division of Pulmonary, Allergy & Critical Care Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. · Pubmed 22054892
  • Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, 19104-4283, USA. · Pubmed 21642245
2010
  • Section of Interventional Pulmonology and Thoracic Oncology, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283, USA. · Pubmed 20068553
2008
  • Thoracic Oncology Research Laboratory, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA. · Pubmed 19074893
2007
  • Thoracic Oncology Gene Therapy Program and Abramson Family Cancer Research Institute, University of Pennsylvania Medical Center, Philadelphia, PA 19104-4283, USA. · Pubmed 17671130
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by Andrew R. Haas about Mesothelioma:

  • Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy. 2016
  • Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy. 2016
  • Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies. 2014
  • Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies. 2013
  • T cells expressing chimeric antigen receptors can cause anaphylaxis in humans. 2013
  • Novel intrapleural therapies for malignant diseases. 2012
  • Gene therapy for lung neoplasms. 2011
  • A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma. 2011
  • Malignant pleural mesothelioma: not immune to the effects of novel therapeutic interventions? 2010
  • A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. 2010
Show List of Full Article Records
Google Searches

Learn more about Andrew R. Haas using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Pennsylvania
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Pennsylvania
2016
  • Division of Hematologic Oncology of the University of Pennsylvania, 3400 Ciciv Center Boulevard, Perelman Center of Advanced Medicine, PA, USA. · Department of Gynecologic Oncology of the University of Pennsylvania, 3400 Ciciv Center Boulevard, Perelman Center of Advanced Medicine, PA, USA. · Section of Interventional Pulmonology & Thoracic Oncology of The University of Pennsylvania, 3400 Ciciv Center Boulevard, Perelman Center of Advanced Medicine, PA, USA. · Hospital of the University of Pennsylvania, 3400 Civic Center Boulevard, Jordan Center, Philadelphia, PA 19104, USA. · Pubmed 26973126
  • Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland. · Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Biostatistics & Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Merck & Co., Inc., Kenilworth, New Jersey. · Wistar Institute, Philadelphia, Pennsylvania. · Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Pubmed 26968202
2014
  • Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA ; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Pubmed 24579088
2013
  • Section of Interventional Pulmonology and Thoracic Oncology, Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, 833 West Gates Building, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA. · Pubmed 23411061
2012
  • Section of Interventional Pulmonology and Thoracic Oncology, Pulmonary, Allergy, and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, PA 19104-4283, USA. · Pubmed 22456231
2013
  • Authors' Affiliations: Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Pubmed 24777247
2011
  • Division of Pulmonary, Allergy & Critical Care Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. · Pubmed 22054892
  • Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, 19104-4283, USA. · Pubmed 21642245
2010
  • Section of Interventional Pulmonology and Thoracic Oncology, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283, USA. · Pubmed 20068553
2008
  • Thoracic Oncology Research Laboratory, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA. · Pubmed 19074893
2007
  • Thoracic Oncology Gene Therapy Program and Abramson Family Cancer Research Institute, University of Pennsylvania Medical Center, Philadelphia, PA 19104-4283, USA. · Pubmed 17671130
Yearly article counts 002012122011
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.